{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T07:44:24Z","timestamp":1782978264648,"version":"3.54.5"},"reference-count":194,"publisher":"Spandidos Publications","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med Int"],"DOI":"10.3892\/mi.2026.326","type":"journal-article","created":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T11:59:43Z","timestamp":1780487983000},"page":"1-24","source":"Crossref","is-referenced-by-count":0,"title":["Regenerative and molecular therapies for myocardial repair (Review)"],"prefix":"10.3892","volume":"6","author":[{"given":"Divina","family":"Puthooran","sequence":"first","affiliation":[{"name":"Faculty of Medicine, Tbilisi State Medical University, Tbilisi 0177, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adlin","family":"Tom","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Ivane Javakhishvili Tbilisi State University, Tbilisi 0179, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Anna","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Ivane Javakhishvili Tbilisi State University, Tbilisi 0179, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harini","family":"Sundaram","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Ivane Javakhishvili Tbilisi State University, Tbilisi 0179, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yousra","family":"Anwar","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, David Tvildiani Medical University, Tbilisi 0159, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirtick","family":"Poovendran","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Tbilisi State Medical University, Tbilisi 0177, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2026,6,3]]},"reference":[{"issue":"625","key":"key20260702095041_b1-MI-6-4-00326","doi-asserted-by":"publisher","DOI":"10.1186\/s12872-025-05022-x","article-title":"Global, regional and national burden of ischemic heart disease and its Attributable risk factors from 1990 to 2021: A systematic analysis of the Global Burden of Disease study 2021","volume":"25","author":"Yang","year":"2025","journal-title":"BMC Cardiovasc Disord"},{"key":"key20260702095041_b2-MI-6-4-00326","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1161\/CIRCRESAHA.116.303577","article-title":"The biological basis for cardiac repair after myocardial infarction: From inflammation to fibrosis","volume":"119","author":"Prabhu","year":"2016","journal-title":"Circ Res"},{"key":"key20260702095041_b3-MI-6-4-00326","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1161\/CIRCULATIONAHA.123.067156","article-title":"A latent cardiomyocyte regeneration potential in human heart disease","volume":"151","author":"Derks","year":"2025","journal-title":"Circulation"},{"key":"key20260702095041_b4-MI-6-4-00326","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.1016\/j.jtcvs.2019.04.109","article-title":"Serial cardiac magnetic resonance imaging after surgical coronary revascularization for left ventricular dysfunction","volume":"159","author":"Hwang","year":"2020","journal-title":"J Thorac Cardiovasc Surg"},{"key":"key20260702095041_b5-MI-6-4-00326","doi-asserted-by":"publisher","first-page":"183","DOI":"10.21037\/cdt.2020.01.11","article-title":"Effects of myocardial viability and left ventricular remodeling on survival of patients with heart failure and reduced ejection fraction after coronary artery bypass grafting","volume":"10","author":"Cao","year":"2020","journal-title":"Cardiovasc Diagn Ther"},{"key":"key20260702095041_b6-MI-6-4-00326","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1093\/ejcts\/ezab122","article-title":"Incidence, determinants and clinical impact of left ventricular function recovery after surgical treatments for ischaemic cardiomyopathy","volume":"60","author":"Nakae","year":"2021","journal-title":"Eur J Cardiothorac Surg"},{"issue":"365","key":"key20260702095041_b7-MI-6-4-00326","doi-asserted-by":"publisher","DOI":"10.1186\/s12872-024-03893-0","article-title":"M1 macrophage-derived exosomes inhibit cardiomyocyte proliferation through delivering miR-155","volume":"24","author":"He","year":"2024","journal-title":"BMC Cardiovasc Disord"},{"issue":"961920","key":"key20260702095041_b8-MI-6-4-00326","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.961920","article-title":"First-in-human pilot trial of combined intracoronary and intravenous mesenchymal stem cell therapy in acute myocardial infarction","volume":"9","author":"Hsiao","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"key20260702095041_b9-MI-6-4-00326","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1253\/circj.CJ-20-0307","article-title":"Safety and efficacy of human Muse cell-based product for acute myocardial infarction in a first-in-human trial","volume":"84","author":"Noda","year":"2020","journal-title":"Circ J"},{"key":"key20260702095041_b10-MI-6-4-00326","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1038\/s41434-020-0171-7","article-title":"Investigation of the safety and feasibility of AAV1\/SERCA2a gene transfer in patients with chronic heart failure supported with a left ventricular assist device-the SERCA-LVAD TRIAL","volume":"27","author":"Lyon","year":"2020","journal-title":"Gene Ther"},{"issue":"19665","key":"key20260702095041_b11-MI-6-4-00326","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-47079-8","article-title":"Development of a potency assay for CD34+ cell-based therapy","volume":"13","author":"Aries","year":"2023","journal-title":"Sci Rep"},{"key":"key20260702095041_b12-MI-6-4-00326","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1016\/j.athoracsur.2019.07.093","article-title":"Intramyocardial bone marrow stem cells in patients undergoing cardiac surgical revascularization","volume":"109","author":"Chan","year":"2020","journal-title":"Ann Thorac Surg"},{"issue":"e59474","key":"key20260702095041_b13-MI-6-4-00326","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.59474","article-title":"Stem cell therapy for myocardial infarction and heart failure: A comprehensive systematic review and critical analysis","volume":"16","author":"Abouzid","year":"2024","journal-title":"Cureus"},{"key":"key20260702095041_b14-MI-6-4-00326","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s12265-021-10168-y","article-title":"Mesenchymal stem cell exosomes in the treatment of myocardial infarction: A systematic review of preclinical in vivo studies","volume":"15","author":"Meng","year":"2022","journal-title":"J Cardiovasc Transl Res"},{"issue":"122858","key":"key20260702095041_b15-MI-6-4-00326","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2024.122858","article-title":"Stem cell and exosome therapies for regenerating damaged myocardium in heart failure","volume":"351","author":"Yahyazadeh","year":"2024","journal-title":"Life Sci"},{"key":"key20260702095041_b16-MI-6-4-00326","first-page":"2156","article-title":"Bone marrow-derived mesenchymal stem cells for heart failure with reduced ejection fraction","volume":"306","author":"Hare","year":"2011","journal-title":"JAMA"},{"key":"key20260702095041_b17-MI-6-4-00326","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.7150\/thno.53326","article-title":"The pivotal roles of exosomes derived from endogenous immune cells and exogenous stem cells in myocardial repair after acute myocardial infarction","volume":"11","author":"Xiong","year":"2021","journal-title":"Theranostics"},{"key":"key20260702095041_b18-MI-6-4-00326","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1093\/bmb\/ldw059","article-title":"Stem cell therapy for ischemic heart diseases","volume":"121","author":"Yu","year":"2017","journal-title":"Br Med Bull"},{"key":"key20260702095041_b19-MI-6-4-00326","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.yjmcc.2023.09.006","article-title":"Current optimized strategies for stem cell-derived extracellular vesicle\/exosomes in cardiac repair","volume":"184","author":"Wu","year":"2023","journal-title":"J Mol Cell Cardiol"},{"key":"key20260702095041_b20-MI-6-4-00326","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.xjon.2022.04.043","article-title":"Therapeutic payload delivery to the myocardium: Evolving strategies and obstacles","volume":"10","author":"Shazly","year":"2022","journal-title":"JTCVS Open"},{"key":"key20260702095041_b21-MI-6-4-00326","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1161\/CIRCINTERVENTIONS.113.001009","article-title":"Intracoronary stem cell infusion after acute myocardial infarction: A meta-analysis and update on clinical trials","volume":"7","author":"de Jong","year":"2014","journal-title":"Circ Cardiovasc Interv"},{"key":"key20260702095041_b22-MI-6-4-00326","doi-asserted-by":"publisher","first-page":"3702","DOI":"10.1093\/eurheartj\/ehaa651","article-title":"The effect of intracoronary infusion of bone marrow-derived mononuclear cells on all-cause mortality in acute myocardial infarction: The BAMI trial","volume":"41","author":"Mathur","year":"2020","journal-title":"Eur Heart J"},{"issue":"600","key":"key20260702095041_b23-MI-6-4-00326","doi-asserted-by":"publisher","DOI":"10.1186\/s13287-021-02667-1","article-title":"Mesenchymal stem cell transplantation after acute myocardial infarction: A meta-analysis of clinical trials","volume":"12","author":"Attar","year":"2021","journal-title":"Stem Cell Res Ther"},{"issue":"e17022","key":"key20260702095041_b24-MI-6-4-00326","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.17022","article-title":"Stem cell therapy for the treatment of myocardial infarction: How far are we now?","volume":"13","author":"Botleroo","year":"2021","journal-title":"Cureus"},{"key":"key20260702095041_b25-MI-6-4-00326","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1002\/sctm.16-0328","article-title":"Effects of transendocardial stem cell injection on ventricular proarrhythmia in patients with ischemic cardiomyopathy: Results from the POSEIDON and TAC-HFT trials","volume":"6","author":"Ramireddy","year":"2017","journal-title":"Stem Cells Transl Med"},{"key":"key20260702095041_b26-MI-6-4-00326","doi-asserted-by":"publisher","first-page":"S54","DOI":"10.1161\/CIRCULATIONAHA.112.092627","article-title":"Administration of cardiac stem cells in patients with ischemic cardiomyopathy: The SCIPIO trial: Surgical aspects and interim analysis of myocardial function and viability by magnetic resonance","volume":"126 (Suppl 11)","author":"Chugh","year":"2012","journal-title":"Circulation"},{"key":"key20260702095041_b27-MI-6-4-00326","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/S0140-6736(12)60195-0","article-title":"Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): A prospective, randomised phase 1 trial","volume":"379","author":"Makkar","year":"2012","journal-title":"Lancet"},{"key":"key20260702095041_b28-MI-6-4-00326","doi-asserted-by":"publisher","first-page":"5","DOI":"10.5339\/gcsp.2013.3","article-title":"CADUCEUS, SCIPIO, ALCADIA: Cell therapy trials using cardiac-derived cells for patients with post myocardial infarction LV dysfunction, still evolving","volume":"2013","author":"Yacoub","year":"2013","journal-title":"Glob Cardiol Sci Pract"},{"key":"key20260702095041_b29-MI-6-4-00326","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1161\/CIRCRESAHA.114.303180","article-title":"Autologous mesenchymal stem cells produce concordant improvements in regional function, tissue perfusion, and fibrotic burden when administered to patients undergoing coronary artery bypass grafting: The Prospective Randomized Study of Mesenchymal Stem Cell Therapy in Patients Undergoing Cardiac Surgery (PROMETHEUS) trial","volume":"114","author":"Karantalis","year":"2014","journal-title":"Circ Res"},{"key":"key20260702095041_b30-MI-6-4-00326","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1002\/ejhf.2178","article-title":"A Phase II study of autologous mesenchymal stromal cells and c-kit positive cardiac cells, alone or in combination, in patients with ischaemic heart failure: the CCTRN CONCERT-HF trial","volume":"23","author":"Bolli","year":"2021","journal-title":"Eur J Heart Fail"},{"key":"key20260702095041_b31-MI-6-4-00326","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1161\/CIRCRESAHA.119.314951","article-title":"Phase 3 DREAM-HF trial of mesenchymal precursor cells in chronic heart failure","volume":"125","author":"Borow","year":"2019","journal-title":"Circ Res"},{"key":"key20260702095041_b32-MI-6-4-00326","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1093\/eurheartj\/eht372","article-title":"Impact of intracoronary bone marrow cell therapy on left ventricular function in the setting of ST-segment elevation myocardial infarction: A collaborative meta-analysis","volume":"35","author":"Delewi","year":"2014","journal-title":"Eur Heart J"},{"issue":"1836","key":"key20260702095041_b33-MI-6-4-00326","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines9121836","article-title":"iPSC therapy for myocardial infarction in large animal models: Land of hope and dreams","volume":"9","author":"Mart\u00ednez-Falguera","year":"2021","journal-title":"Biomedicines"},{"issue":"987","key":"key20260702095041_b34-MI-6-4-00326","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25020987","article-title":"Induced pluripotent stem cell-derived cardiomyocytes therapy for ischemic heart disease in animal models: A meta-analysis","volume":"25","author":"Vo","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"601560","key":"key20260702095041_b35-MI-6-4-00326","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2020.601560","article-title":"Cell therapy with human ESC-derived cardiac cells: Clinical perspectives","volume":"8","author":"Menasch\u00e9","year":"2020","journal-title":"Front Bioeng Biotechnol"},{"issue":"605","key":"key20260702095041_b36-MI-6-4-00326","doi-asserted-by":"publisher","DOI":"10.3390\/bioengineering9110605","article-title":"Engineered tissue for cardiac regeneration: Current status and future perspectives","volume":"9","author":"Li","year":"2022","journal-title":"Bioengineering (Basel)"},{"issue":"5772","key":"key20260702095041_b37-MI-6-4-00326","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25115772","article-title":"Current status of cardiac regenerative therapy using induced pluripotent stem cells","volume":"25","author":"Sugiura","year":"2024","journal-title":"Int J Mol Sci"},{"key":"key20260702095041_b38-MI-6-4-00326","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1007\/s12015-021-10289-6","article-title":"Extracellular vesicles as a cell-free therapy for cardiac repair: A systematic review and meta-analysis of randomized controlled preclinical trials in animal myocardial infarction models","volume":"18","author":"Khan","year":"2022","journal-title":"Stem Cell Rev Rep"},{"issue":"824","key":"key20260702095041_b39-MI-6-4-00326","doi-asserted-by":"publisher","DOI":"10.3390\/gels9100824","article-title":"Engineered vesicles and hydrogel technologies for myocardial regeneration","volume":"9","author":"Ghassemi","year":"2023","journal-title":"Gels"},{"key":"key20260702095041_b40-MI-6-4-00326","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/S0140-6736(22)00012-5","article-title":"Repeated intravenous cardiosphere-derived cell therapy in late-stage Duchenne muscular dystrophy (HOPE-2): A multicentre, randomised, double-blind, placebo-controlled, phase 2 trial","volume":"399","author":"McDonald","year":"2022","journal-title":"Lancet"},{"issue":"2056","key":"key20260702095041_b41-MI-6-4-00326","doi-asserted-by":"publisher","DOI":"10.3390\/medicina61112056","article-title":"Arrhythmogenic risk in iPSC-derived cardiomyocytes: Current limitations and therapeutic perspectives","volume":"61","author":"Shahannaz","year":"2025","journal-title":"Medicina"},{"key":"key20260702095041_b42-MI-6-4-00326","doi-asserted-by":"publisher","first-page":"S2312","DOI":"10.21037\/jtd.2017.12.92","article-title":"Engineered circulatory scaffolds for building cardiac tissue","volume":"10 (Suppl 20)","author":"Huang","year":"2018","journal-title":"J Thorac Dis"},{"key":"key20260702095041_b43-MI-6-4-00326","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.1161\/CIRCULATIONAHA.123.067097","article-title":"Advanced cardiac patches for the treatment of myocardial infarction","volume":"149","author":"Liu","year":"2024","journal-title":"Circulation"},{"issue":"122","key":"key20260702095041_b44-MI-6-4-00326","doi-asserted-by":"publisher","DOI":"10.3390\/bioengineering7040122","article-title":"Mechanical considerations of electrospun scaffolds for myocardial tissue and regenerative engineering","volume":"7","author":"Nguyen-Truong","year":"2020","journal-title":"Bioengineering"},{"issue":"111425","key":"key20260702095041_b45-MI-6-4-00326","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.111425","article-title":"Stem cell-based approaches in cardiac tissue engineering: Controlling the microenvironment for autologous cells","volume":"138","author":"Augustine","year":"2021","journal-title":"Biomed Pharmacother"},{"issue":"855763","key":"key20260702095041_b46-MI-6-4-00326","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.855763","article-title":"Human engineered heart tissue models for disease modeling and drug discovery","volume":"10","author":"Tani","year":"2022","journal-title":"Front Cell Dev Biol"},{"issue":"1412","key":"key20260702095041_b47-MI-6-4-00326","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21682-7","article-title":"Minimally invasive delivery of therapeutic agents by hydrogel injection into the pericardial cavity for cardiac repair","volume":"12","author":"Zhu","year":"2021","journal-title":"Nat Commun"},{"issue":"1878","key":"key20260702095041_b48-MI-6-4-00326","doi-asserted-by":"publisher","DOI":"10.3390\/polym16131878","article-title":"Injectable hydrogels in cardiovascular tissue engineering","volume":"16","author":"Patel","year":"2024","journal-title":"Polymers"},{"key":"key20260702095041_b49-MI-6-4-00326","doi-asserted-by":"publisher","first-page":"3946","DOI":"10.7150\/ijms.118408","article-title":"The application of epicardium in heart failure treatment: Opportunities and challenges","volume":"22","author":"Zhou","year":"2025","journal-title":"Int J Med Sci"},{"issue":"e2200055","key":"key20260702095041_b50-MI-6-4-00326","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202200055","article-title":"Recent advances in designing electroconductive biomaterials for cardiac tissue engineering","volume":"11","author":"Ghovvati","year":"2022","journal-title":"Adv Healthc Mater"},{"key":"key20260702095041_b51-MI-6-4-00326","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.actbio.2021.08.031","article-title":"Electroconductive biomaterials for cardiac tissue engineering","volume":"139","author":"Esmaeili","year":"2021","journal-title":"Acta Biomater"},{"key":"key20260702095041_b52-MI-6-4-00326","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1089\/ten.TEB.2020.0343","article-title":"Engineering three-dimensional vascularized cardiac tissues","volume":"28","author":"Williams","year":"2021","journal-title":"Tissue Eng Part B Rev"},{"issue":"77","key":"key20260702095041_b53-MI-6-4-00326","doi-asserted-by":"publisher","DOI":"10.1007\/s10856-025-06923-1","article-title":"Advancing cardiac patch viability and functionality: Innovations in scaffold design and cellular optimization","volume":"36","author":"Eliwa","year":"2025","journal-title":"J Mater Sci Mater Med"},{"key":"key20260702095041_b54-MI-6-4-00326","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.mattod.2023.09.005","article-title":"Electroactive biomaterials synergizing with electrostimulation for cardiac tissue regeneration and function-monitoring","volume":"70","author":"Zhang","year":"2023","journal-title":"Mater Today"},{"key":"key20260702095041_b55-MI-6-4-00326","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1002\/jbm.a.36874","article-title":"Current advances in biodegradable synthetic polymer based cardiac patches","volume":"108","author":"McMahan","year":"2020","journal-title":"J Biomed Mater Res A"},{"key":"key20260702095041_b56-MI-6-4-00326","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.biomaterials.2019.03.015","article-title":"Engineering a naturally-derived adhesive and conductive cardiopatch","volume":"207","author":"Walker","year":"2019","journal-title":"Biomaterials"},{"issue":"213579","key":"key20260702095041_b57-MI-6-4-00326","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioadv.2023.213579","article-title":"3D printing of thick myocardial tissue constructs with anisotropic myofibers and perfusable vascular channels","volume":"153","author":"Cui","year":"2023","journal-title":"Biomater Adv"},{"issue":"1177","key":"key20260702095041_b58-MI-6-4-00326","doi-asserted-by":"publisher","DOI":"10.3390\/polym15051177","article-title":"Progress in biomaterials for cardiac tissue engineering and regeneration","volume":"15","author":"Udri\u0219te","year":"2023","journal-title":"Polymers"},{"issue":"e2504765","key":"key20260702095041_b59-MI-6-4-00326","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202504765","article-title":"Volumetric 3D printing and melt-electrowriting to fabricate implantable reinforced cardiac tissue patches","volume":"37","author":"Jones","year":"2025","journal-title":"Adv Mater"},{"issue":"1094397","key":"key20260702095041_b60-MI-6-4-00326","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2023.1094397","article-title":"Engineering a conduction-consistent cardiac patch with rGO\/PLCL electrospun nanofibrous membranes and human iPSC-derived cardiomyocytes","volume":"11","author":"Tan","year":"2023","journal-title":"Front Bioeng Biotechnol"},{"issue":"4133","key":"key20260702095041_b61-MI-6-4-00326","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-48468-x","article-title":"E-cardiac patch to sense and repair infarcted myocardium","volume":"15","author":"Qiu","year":"2024","journal-title":"Nat Commun"},{"issue":"102729","key":"key20260702095041_b62-MI-6-4-00326","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2020.102729","article-title":"First-in-human PeriCord cardiac bioimplant: Scalability and GMP manufacturing of an allogeneic engineered tissue graft","volume":"54","author":"Prat-Vidal","year":"2020","journal-title":"EBioMedicine"},{"issue":"583360","key":"key20260702095041_b63-MI-6-4-00326","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2020.583360","article-title":"A novel restorative pulmonary valve conduit: Early outcomes of two clinical trials","volume":"7","author":"Morales","year":"2021","journal-title":"Front Cardiovasc Med"},{"issue":"255","key":"key20260702095041_b64-MI-6-4-00326","doi-asserted-by":"publisher","DOI":"10.1186\/s13019-023-02358-3","article-title":"Second-generation extracellular matrix patch for epicardial infarct repair","volume":"18","author":"Bhatt","year":"2023","journal-title":"J Cardiothorac Surg"},{"issue":"54","key":"key20260702095041_b65-MI-6-4-00326","article-title":"Perspective on the development of a bioengineered patch to treat heart failure: Rationale and proposed design of a phase I clinical trial","volume":"6","author":"Goldman","year":"2022","journal-title":"Vessel Plus"},{"issue":"714356","key":"key20260702095041_b66-MI-6-4-00326","doi-asserted-by":"publisher","DOI":"10.3389\/frobt.2021.714356","article-title":"Cardiac patch transplantation instruments for robotic minimally invasive cardiac surgery: Initial proof-of-concept designs and surgery in a porcine cadaver","volume":"8","author":"Roche","year":"2022","journal-title":"Front Robotics AI"},{"issue":"597410","key":"key20260702095041_b67-MI-6-4-00326","doi-asserted-by":"publisher","DOI":"10.3389\/fsurg.2021.597410","article-title":"The importance of culture change associated with novel surgical approaches and innovation: Does perioperative care transcend technical considerations for pulmonary lobectomy?","volume":"8","author":"Freystaetter","year":"2021","journal-title":"Front Surg"},{"issue":"1203","key":"key20260702095041_b68-MI-6-4-00326","doi-asserted-by":"publisher","DOI":"10.1038\/s42003-023-05564-w","article-title":"Biologically derived epicardial patch induces macrophage mediated pathophysiologic repair in chronically infarcted swine hearts","volume":"6","author":"Lancaster","year":"2023","journal-title":"Commun Biol"},{"issue":"112936","key":"key20260702095041_b69-MI-6-4-00326","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2022.112936","article-title":"Fibrin-based cardiac patch containing neuregulin-1 for heart repair after myocardial infarction","volume":"220","author":"Chang","year":"2022","journal-title":"Colloids Surf B Biointerfaces"},{"issue":"e144068","key":"key20260702095041_b70-MI-6-4-00326","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.144068","article-title":"In vivo grafting of large engineered heart tissue patches for cardiac repair","volume":"6","author":"Jabbour","year":"2021","journal-title":"JCI Insight"},{"issue":"61","key":"key20260702095041_b71-MI-6-4-00326","doi-asserted-by":"publisher","DOI":"10.1186\/s13019-019-0871-5","article-title":"Pericardial closure with extracellular matrix scaffold following cardiac surgery associated with a reduction of postoperative complications and 30-day hospital readmissions","volume":"14","author":"Rego","year":"2019","journal-title":"J Cardiothorac Surg"},{"issue":"e10706","key":"key20260702095041_b72-MI-6-4-00326","doi-asserted-by":"publisher","DOI":"10.1002\/btm2.10706","article-title":"Cardiovascular patches applied in congenital cardiac surgery: Current materials and prospects","volume":"10","author":"Sun","year":"2024","journal-title":"Bioeng Transl Med"},{"issue":"564","key":"key20260702095041_b73-MI-6-4-00326","doi-asserted-by":"publisher","DOI":"10.3390\/gels11070564","article-title":"Hydrogels in cardiac surgery: Versatile platforms for tissue repair, adhesion prevention, and localized therapeutics","volume":"11","author":"Hong","year":"2025","journal-title":"Gels"},{"issue":"e2101018","key":"key20260702095041_b74-MI-6-4-00326","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202101018","article-title":"A prevascularized polyurethane-reinforced fibrin patch improves regenerative remodeling in a rat right ventricle replacement model","volume":"10","author":"Tao","year":"2021","journal-title":"Adv Healthc Mater"},{"key":"key20260702095041_b75-MI-6-4-00326","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.jare.2024.11.026","article-title":"Self-adhesion conductive cardiac patch based on methoxytriethylene glycol-functionalized graphene effectively improves cardiac function after myocardial infarction","volume":"76","author":"Wang","year":"2024","journal-title":"J Adv Res"},{"issue":"e2303033","key":"key20260702095041_b76-MI-6-4-00326","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202303033","article-title":"An intrinsically magnetic epicardial patch for rapid vascular reconstruction and drug delivery","volume":"10","author":"Qian","year":"2023","journal-title":"Adv Sci"},{"issue":"530","key":"key20260702095041_b77-MI-6-4-00326","doi-asserted-by":"publisher","DOI":"10.3390\/gels11070530","article-title":"Recent achievements of epicardial patch electronics using adhesive and conductive hydrogels","volume":"11","author":"Lee","year":"2025","journal-title":"Gels"},{"key":"key20260702095041_b78-MI-6-4-00326","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.actbio.2025.08.060","article-title":"An anisotropic cardiac patch with barbed microneedles for enhanced tissue anchorage and myocardial repair","volume":"205","author":"Shan","year":"2025","journal-title":"Acta Biomater"},{"key":"key20260702095041_b79-MI-6-4-00326","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/s41586-024-08463-0","article-title":"Engineered heart muscle allografts for heart repair in primates and humans","volume":"639","author":"Jebran","year":"2025","journal-title":"Nature"},{"issue":"4501","key":"key20260702095041_b80-MI-6-4-00326","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-24804-3","article-title":"Nitrate-functionalized patch confers cardioprotection and improves heart repair after myocardial infarction via local nitric oxide delivery","volume":"12","author":"Zhu","year":"2021","journal-title":"Nat Commun"},{"issue":"5995","key":"key20260702095041_b81-MI-6-4-00326","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26135995","article-title":"Echocardiographic assessment of cardiac function in mouse models of heart disease","volume":"26","author":"Salerno","year":"2025","journal-title":"Int J Mol Sci"},{"key":"key20260702095041_b82-MI-6-4-00326","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1111\/joim.13308","article-title":"Gene therapy for ischaemic heart disease and heart failure","volume":"290","author":"Korpela","year":"2021","journal-title":"J Intern Med"},{"key":"key20260702095041_b83-MI-6-4-00326","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.jconrel.2022.01.027","article-title":"Delivery of modified mRNA to damaged myocardium by systemic administration of lipid nanoparticles","volume":"343","author":"Evers","year":"2022","journal-title":"J Control Release"},{"issue":"833335","key":"key20260702095041_b84-MI-6-4-00326","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.833335","article-title":"Targeted delivery for cardiac regeneration: Comparison of intracoronary infusion and intramyocardial injection in porcine hearts","volume":"9","author":"Vekstein","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"key20260702095041_b85-MI-6-4-00326","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1002\/ehf2.15124","article-title":"Transendocardial injection of expanded autologous CD34+ cells after myocardial infarction: Design of the EXCELLENT trial","volume":"12","author":"Roncalli","year":"2024","journal-title":"ESC Heart Fail"},{"key":"key20260702095041_b86-MI-6-4-00326","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1016\/j.ymthe.2022.11.017","article-title":"Direct intramyocardial injection of VEGF mRNA in patients undergoing coronary artery bypass grafting","volume":"31","author":"Anttila","year":"2023","journal-title":"Mol Ther"},{"key":"key20260702095041_b87-MI-6-4-00326","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.cardfail.2009.01.013","article-title":"Calcium upregulation by percutaneous administration of gene therapy in cardiac disease (CUPID): A first-in-human phase 1\/2 clinical trial","volume":"15","author":"Jaski","year":"2009","journal-title":"J Card Fail"},{"key":"key20260702095041_b88-MI-6-4-00326","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1161\/CIRCULATIONAHA.111.022889","article-title":"Calcium upregulation by percutaneous administration of gene therapy in cardiac disease (CUPID): A phase 2 trial of intracoronary gene therapy of sarcoplasmic reticulum Ca2+-ATPase in patients with advanced heart failure","volume":"124","author":"Jessup","year":"2011","journal-title":"Circulation"},{"key":"key20260702095041_b89-MI-6-4-00326","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1016\/S0140-6736(16)00082-9","article-title":"Calcium upregulation by percutaneous administration of gene therapy in patients with cardiac disease (CUPID 2): A randomized, multinational, double-blind, placebo-controlled, phase 2b trial","volume":"387","author":"Greenberg","year":"2016","journal-title":"Lancet"},{"key":"key20260702095041_b90-MI-6-4-00326","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1007\/s10741-025-10487-1","article-title":"SERCA2a dysfunction in the pathophysiology of heart failure with preserved ejection fraction: A direct role is yet to be established","volume":"30","author":"Shooshtarian","year":"2025","journal-title":"Heart Fail Rev"},{"key":"key20260702095041_b91-MI-6-4-00326","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/j.hlc.2023.06.704","article-title":"In search of Adeno-Associated virus vectors with enhanced cardiac tropism for gene therapy","volume":"32","author":"Sasaki","year":"2023","journal-title":"Heart Lung Circ"},{"key":"key20260702095041_b92-MI-6-4-00326","doi-asserted-by":"publisher","first-page":"3845","DOI":"10.1038\/s41591-025-04011-z","article-title":"Cardiotropic AAV gene therapy for heart failure: A phase 1 trial","volume":"31","author":"Henry","year":"2025","journal-title":"Nat Med"},{"key":"key20260702095041_b93-MI-6-4-00326","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1016\/j.omtn.2021.04.018","article-title":"Improved cardiac-specific delivery of RAGE siRNA within small extracellular vesicles engineered to express intense cardiac targeting peptide attenuates myocarditis","volume":"24","author":"Kim","year":"2021","journal-title":"Mol Ther Nucleic Acids"},{"issue":"102747","key":"key20260702095041_b94-MI-6-4-00326","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtn.2025.102747","article-title":"Optimization of siRNA therapeutics targeting MIAT for cardioprotection in myocardial ischemia\/reperfusion injury","volume":"36","author":"Ma","year":"2025","journal-title":"Mol Ther Nucleic Acids"},{"key":"key20260702095041_b95-MI-6-4-00326","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.ymthe.2024.01.008","article-title":"Application of improved GalNAc conjugation in development of cost-effective siRNA therapies targeting cardiovascular diseases","volume":"32","author":"Li","year":"2024","journal-title":"Mol Ther"},{"key":"key20260702095041_b96-MI-6-4-00326","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1161\/CIRCULATIONAHA.123.065506","article-title":"Targeting NPM1 epigenetically promotes postinfarction cardiac repair by reprogramming reparative macrophage metabolism","volume":"149","author":"Zhang","year":"2024","journal-title":"Circulation"},{"issue":"674","key":"key20260702095041_b97-MI-6-4-00326","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2020.00674","article-title":"Metabolic modulation of macrophage function post myocardial infarction","volume":"11","author":"Zhao","year":"2020","journal-title":"Front Physiol"},{"issue":"1782933","key":"key20260702095041_b98-MI-6-4-00326","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2026.1782933","article-title":"Efferocytosis in myocardial infarction: The regulatory core from inflammation resolution to cardiac repair","volume":"17","author":"Meng","year":"2026","journal-title":"Front Immunol"},{"issue":"3884","key":"key20260702095041_b99-MI-6-4-00326","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11133884","article-title":"Antisense oligonucleotides and small interfering RNA for the treatment of dyslipidemias","volume":"11","author":"Gareri","year":"2022","journal-title":"J Clin Med"},{"issue":"15514","key":"key20260702095041_b100-MI-6-4-00326","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232415514","article-title":"Modified mRNA therapeutics for heart diseases","volume":"23","author":"Magadum","year":"2022","journal-title":"Int J Mol Sci"},{"key":"key20260702095041_b101-MI-6-4-00326","doi-asserted-by":"publisher","first-page":"483","DOI":"10.3892\/mmr.2020.11085","article-title":"MicroRNA-93 promotes angiogenesis and attenuates remodeling via inactivation of the Hippo\/Yap pathway by targeting Lats2 after myocardial infarction\u03c9","volume":"22","author":"Ma","year":"2020","journal-title":"Mol Med Rep"},{"key":"key20260702095041_b102-MI-6-4-00326","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1161\/CIRCULATIONAHA.123.067890","article-title":"Allele-specific suppression of variant MHC with high-precision RNA nuclease CRISPR-Cas13d prevents hypertrophic cardiomyopathy","volume":"150","author":"Yang","year":"2024","journal-title":"Circulation"},{"issue":"e3000941","key":"key20260702095041_b103-MI-6-4-00326","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.3000941","article-title":"YAP\/TAZ deficiency reprograms macrophage phenotype and improves infarct healing and cardiac function after myocardial infarction","volume":"18","author":"Mia","year":"2020","journal-title":"PLoS Biol"},{"issue":"e79372","key":"key20260702095041_b104-MI-6-4-00326","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.79372","article-title":"The future of clustered regularly interspaced short palindromic repeats (CRISPR)-Cas9 gene therapy in cardiomyopathies: A review of its therapeutic potential and emerging applications","volume":"17","author":"Moradi","year":"2025","journal-title":"Cureus"},{"key":"key20260702095041_b105-MI-6-4-00326","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1177\/1535676020934917","article-title":"Safeguards for using viral vector systems in human gene therapy: A resource for biosafety professionals mitigating risks in health care settings","volume":"25","author":"Brown","year":"2020","journal-title":"Appl Biosaf"},{"key":"key20260702095041_b106-MI-6-4-00326","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1177\/1535676020942195","article-title":"Biosafety practices for in vivo viral-mediated gene therapy in the health care setting","volume":"25","author":"Blind","year":"2020","journal-title":"Appl Biosaf"},{"key":"key20260702095041_b107-MI-6-4-00326","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1089\/apb.2022.0020","article-title":"FDA guidance on shedding and environmental impact in clinical trials involving gene therapy products","volume":"27","author":"Eisenman","year":"2022","journal-title":"Appl Biosaf"},{"key":"key20260702095041_b108-MI-6-4-00326","doi-asserted-by":"publisher","first-page":"3220","DOI":"10.1016\/j.ymthe.2024.07.016","article-title":"A systematic review of immunosuppressive protocols used in AAV gene therapy for monogenic disorders","volume":"32","author":"Vrellaku","year":"2024","journal-title":"Mol Ther"},{"key":"key20260702095041_b109-MI-6-4-00326","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1016\/j.jcyt.2024.11.015","article-title":"Considerations for manufacturing of cell and gene medicines for clinical development","volume":"27","author":"Lowdell","year":"2025","journal-title":"Cytotherapy"},{"key":"key20260702095041_b110-MI-6-4-00326","doi-asserted-by":"publisher","first-page":"4092","DOI":"10.1093\/eurheartj\/ehaa659","article-title":"Time-to-treatment initiation of colchicine and cardiovascular outcomes after myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT)","volume":"41","author":"Bouabdallaoui","year":"2020","journal-title":"Eur Heart J"},{"key":"key20260702095041_b111-MI-6-4-00326","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1016\/j.jacc.2020.08.011","article-title":"Inhibition of interleukin-1\u03b2 and reduction in atherothrombotic cardiovascular events in the CANTOS trial","volume":"76","author":"Everett","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"key20260702095041_b112-MI-6-4-00326","doi-asserted-by":"publisher","first-page":"2414","DOI":"10.7150\/ijbs.47180","article-title":"The roles of noncardiomyocytes in cardiac remodeling","volume":"16","author":"Yang","year":"2020","journal-title":"Int J Biol Sci"},{"key":"key20260702095041_b113-MI-6-4-00326","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1038\/s41591-021-01452-0","article-title":"Pirfenidone in heart failure with preserved ejection fraction: A randomized phase 2 trial","volume":"27","author":"Lewis","year":"2021","journal-title":"Nat Med"},{"issue":"e024668","key":"key20260702095041_b114-MI-6-4-00326","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.121.024668","article-title":"Characteristics associated with Growth differentiation factor 15 in heart failure with preserved ejection fraction and the impact of pirfenidone","volume":"11","author":"Lewis","year":"2022","journal-title":"J Am Heart Assoc"},{"key":"key20260702095041_b115-MI-6-4-00326","doi-asserted-by":"publisher","first-page":"4421","DOI":"10.1093\/eurheartj\/ehac494","article-title":"Empagliflozin in acute myocardial infarction: The EMMY trial","volume":"43","author":"von Lewinski","year":"2022","journal-title":"Eur Heart J"},{"key":"key20260702095041_b116-MI-6-4-00326","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1093\/eurheartj\/ehac530","article-title":"Impact of empagliflozin on decongestion in acute heart failure: The EMPULSE trial","volume":"44","author":"Biegus","year":"2023","journal-title":"Eur Heart J"},{"key":"key20260702095041_b117-MI-6-4-00326","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.jacbts.2018.12.005","article-title":"Elamipretide improves mitochondrial function in the failing human heart","volume":"4","author":"Chatfield","year":"2019","journal-title":"JACC Basic Transl Sci"},{"issue":"e002579","key":"key20260702095041_b118-MI-6-4-00326","doi-asserted-by":"publisher","DOI":"10.1136\/openhrt-2023-002579","article-title":"Effects of trimetazidine on heart failure with reduced ejection fraction and associated clinical outcomes: A systematic review and meta-analysis","volume":"11","author":"Nassiri","year":"2024","journal-title":"Open Heart"},{"key":"key20260702095041_b119-MI-6-4-00326","doi-asserted-by":"publisher","first-page":"13","DOI":"10.62347\/ASXF2065","article-title":"Metabolic intervention with trimetazidine improves intracardiac hemodynamics and reduces re-hospitalizations in patients with advanced heart failure","volume":"15","author":"Sisakian","year":"2025","journal-title":"Am J Cardiovasc Dis"},{"issue":"111540","key":"key20260702095041_b120-MI-6-4-00326","doi-asserted-by":"publisher","DOI":"10.1016\/j.mad.2021.111540","article-title":"Senescence and senolytics in cardiovascular disease: Promise and potential pitfalls","volume":"198","author":"Owens","year":"2021","journal-title":"Mech Ageing Dev"},{"key":"key20260702095041_b121-MI-6-4-00326","doi-asserted-by":"publisher","first-page":"2629","DOI":"10.1016\/j.jmb.2019.05.036","article-title":"Regulation of survival networks in senescent cells: From mechanisms to interventions","volume":"431","author":"Soto-Gamez","year":"2019","journal-title":"J Mol Biol"},{"issue":"111927","key":"key20260702095041_b122-MI-6-4-00326","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2020.111927","article-title":"The role of lamin B receptor in the regulation of senescence-associated secretory phenotype (SASP)","volume":"390","author":"En","year":"2020","journal-title":"Exp Cell Res"},{"issue":"e100492","key":"key20260702095041_b123-MI-6-4-00326","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2018100492","article-title":"Length-independent telomere damage drives post-mitotic cardiomyocyte senescence","volume":"38","author":"Anderson","year":"2019","journal-title":"EMBO J"},{"issue":"e13249","key":"key20260702095041_b124-MI-6-4-00326","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13249","article-title":"Clearance of senescent cells during cardiac ischemia-reperfusion injury improves recovery","volume":"19","author":"Dookun","year":"2020","journal-title":"Aging Cell"},{"issue":"e13142","key":"key20260702095041_b125-MI-6-4-00326","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13142","article-title":"Galacto-conjugation of navitoclax as an efficient strategy to increase senolytic specificity and reduce platelet toxicity","volume":"19","author":"Gonz\u00e1lez-Gualda","year":"2020","journal-title":"Aging Cell"},{"key":"key20260702095041_b126-MI-6-4-00326","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.actbio.2021.08.028","article-title":"Local delivery of a senolytic drug in ischemia and reperfusion-injured heart attenuates cardiac remodeling and restores impaired cardiac function","volume":"135","author":"Lee","year":"2021","journal-title":"Acta Biomater"},{"issue":"726889","key":"key20260702095041_b127-MI-6-4-00326","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.726889","article-title":"Epicardial transplantation of autologous cardiac micrografts during coronary artery bypass surgery","volume":"8","author":"Nummi","year":"2021","journal-title":"Front Cardiovasc Med"},{"issue":"1195","key":"key20260702095041_b128-MI-6-4-00326","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics12121195","article-title":"Scaffolds and extracellular vesicles as a promising approach for cardiac regeneration after myocardial infarction","volume":"12","author":"Riaud","year":"2020","journal-title":"Pharmaceutics"},{"issue":"399","key":"key20260702095041_b129-MI-6-4-00326","doi-asserted-by":"publisher","DOI":"10.3390\/jcdd10090399","article-title":"Robotic-assisted solutions for invasive cardiology, cardiac surgery and routine on-ward tasks: A narrative review","volume":"10","author":"Koulaouzidis","year":"2023","journal-title":"J Cardiovasc Dev Dis"},{"key":"key20260702095041_b130-MI-6-4-00326","doi-asserted-by":"publisher","first-page":"360","DOI":"10.5114\/aic.2022.121124","article-title":"Hybrid techniques for myocardial regeneration: State of the art and future perspectives","volume":"18","author":"K\u0119dziora","year":"2022","journal-title":"Adv Interv Cardiol"},{"key":"key20260702095041_b131-MI-6-4-00326","doi-asserted-by":"publisher","first-page":"4150","DOI":"10.1111\/jocs.17000","article-title":"Use of computed tomography for preoperative planning in patients undergoing coronary artery bypass grafting","volume":"37","author":"Miller","year":"2022","journal-title":"J Card Surg"},{"key":"key20260702095041_b132-MI-6-4-00326","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1007\/s10554-024-03057-3","article-title":"Determination of viable myocardium through delayed enhancement cardiac magnetic resonance imaging combined with 18F-FDG PET myocardial perfusion\/metabolic imaging before CABG","volume":"40","author":"Xu","year":"2024","journal-title":"Int J Cardiovasc Imaging"},{"key":"key20260702095041_b133-MI-6-4-00326","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1055\/s-0042-1754362","article-title":"Role of cardiac MRI including LGE, T1 and T2 mapping in the assessment of cardiac involvement in patients with nonspecific aorto-arteritis: A prospective study","volume":"32","author":"Chandrashekhara","year":"2022","journal-title":"Indian J Radiol Imaging"},{"issue":"93","key":"key20260702095041_b134-MI-6-4-00326","doi-asserted-by":"publisher","DOI":"10.3390\/jcdd12030093","article-title":"Intraoperative transesophageal echocardiographic guidance in cardiac surgery","volume":"12","author":"Dimitroglou","year":"2025","journal-title":"J Cardiovasc Dev Dis"},{"issue":"e22649","key":"key20260702095041_b135-MI-6-4-00326","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.22649","article-title":"Intraoperative epicardial ultra-high-frequency ultrasound in coronary artery bypass grafting surgery","volume":"14","author":"Fritz","year":"2022","journal-title":"Cureus"},{"key":"key20260702095041_b136-MI-6-4-00326","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/978-1-0716-2707-5_14","article-title":"Endocardial gene delivery using NOGA catheter system","volume":"2573","author":"Siimes","year":"2022","journal-title":"Methods Mol Biol"},{"issue":"37","key":"key20260702095041_b137-MI-6-4-00326","doi-asserted-by":"publisher","DOI":"10.1186\/s12880-021-00562-y","article-title":"A novel fluorescent cardiac imaging system for preclinical intraoperative angiography","volume":"21","author":"Mashalchi","year":"2021","journal-title":"BMC Med Imaging"},{"issue":"ezab468","key":"key20260702095041_b138-MI-6-4-00326","doi-asserted-by":"publisher","DOI":"10.1093\/ejcts\/ezab468","article-title":"Diagnostic performance of echocardiography to predict cardiac tamponade after cardiac surgery","volume":"62","author":"Ellenbroek","year":"2022","journal-title":"Eur J Cardiothorac Surg"},{"key":"key20260702095041_b139-MI-6-4-00326","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1093\/icvts\/ivz251","article-title":"2019 EACTS\/EACTA\/EBCP guidelines on cardiopulmonary bypass in adult cardiac surgery","volume":"30","author":"Puis","year":"2019","journal-title":"Interact Cardiovasc Thorac Surg"},{"issue":"934","key":"key20260702095041_b140-MI-6-4-00326","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics14090934","article-title":"Length and type of antibiotic prophylaxis for infection prevention in adult patients in the cardiac surgery intensive care unit: A narrative review","volume":"14","author":"Barbato","year":"2025","journal-title":"Antibiotics (Basel)"},{"key":"key20260702095041_b141-MI-6-4-00326","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1007\/s12265-020-10035-2","article-title":"Requirements for proper immunosuppressive regimens to limit translational failure of cardiac cell therapy in preclinical large animal models","volume":"14","author":"Demkes","year":"2021","journal-title":"J Cardiovasc Transl Res"},{"issue":"euad057","key":"key20260702095041_b142-MI-6-4-00326","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/euad057","article-title":"Impact of peri-procedural management of direct oral anticoagulants on pocket haematoma after cardiac electronic device implantation: The StimAOD multicentre prospective study","volume":"25","author":"Martin","year":"2023","journal-title":"Europace"},{"issue":"991","key":"key20260702095041_b143-MI-6-4-00326","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics13100991","article-title":"Antibiotic prophylaxis and treatment for cardiac device infections","volume":"13","author":"Pandozi","year":"2024","journal-title":"Antibiotics (Basel)"},{"key":"key20260702095041_b144-MI-6-4-00326","doi-asserted-by":"publisher","first-page":"5997","DOI":"10.19102\/icrm.2024.15085","article-title":"Comparison of postoperative continuous wireless cardiac rhythm monitoring with traditional telemetry in cardiac surgery patients: The SMART-TEL study","volume":"15","author":"Pidoux","year":"2024","journal-title":"J Innov Card Rhythm Manag"},{"issue":"1182209","key":"key20260702095041_b145-MI-6-4-00326","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2023.1182209","article-title":"Safety confirmation of induced pluripotent stem cell-derived cardiomyocyte patch transplantation for ischemic cardiomyopathy: First three case reports","volume":"10","author":"Kawamura","year":"2023","journal-title":"Front Cardiovasc Med"},{"issue":"355","key":"key20260702095041_b146-MI-6-4-00326","doi-asserted-by":"publisher","DOI":"10.31083\/j.rcm2510355","article-title":"The value of biomarkers in major cardiovascular surgery necessitating cardiopulmonary bypass","volume":"25","author":"Stef","year":"2024","journal-title":"Rev Cardiovasc Med"},{"issue":"290","key":"key20260702095041_b147-MI-6-4-00326","doi-asserted-by":"publisher","DOI":"10.1186\/s13287-024-03891-1","article-title":"Mid- to long-term efficacy and safety of stem cell therapy for acute myocardial infarction: A systematic review and meta-analysis","volume":"15","author":"Lee","year":"2024","journal-title":"Stem Cell Res Ther"},{"key":"key20260702095041_b148-MI-6-4-00326","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1161\/CIRCRESAHA.118.312823","article-title":"Safety and efficacy of intracoronary infusion of allogeneic human cardiac stem cells in patients with ST-segment elevation myocardial infarction and left ventricular dysfunction","volume":"123","author":"Fern\u00e1ndez-Avil\u00e9s","year":"2018","journal-title":"Circ Res"},{"key":"key20260702095041_b149-MI-6-4-00326","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1002\/sctm.18-0120","article-title":"Safety and efficacy of adult stem cell therapy for acute myocardial infarction and ischemic heart failure (SafeCell Heart): A systematic review and meta-analysis","volume":"7","author":"Lalu","year":"2018","journal-title":"Stem Cells Transl Med"},{"issue":"e003301","key":"key20260702095041_b150-MI-6-4-00326","doi-asserted-by":"publisher","DOI":"10.1136\/openhrt-2025-003301","article-title":"Safety and efficacy of stem cell therapy in acute myocardial infarction: A systematic review and meta-analysis of adverse events, infarct size and left ventricular ejection fraction assessed by CMR","volume":"12","author":"Moeswir","year":"2025","journal-title":"Open Heart"},{"key":"key20260702095041_b151-MI-6-4-00326","doi-asserted-by":"publisher","first-page":"36","DOI":"10.7150\/ijms.21666","article-title":"Ethical and safety issues of stem cell-based therapy","volume":"15","author":"Volarevic","year":"2018","journal-title":"Int J Med Sci"},{"key":"key20260702095041_b152-MI-6-4-00326","doi-asserted-by":"publisher","first-page":"6257","DOI":"10.1002\/jcp.29554","article-title":"Arrhythmogenic risks of stem cell replacement therapy for cardiovascular diseases","volume":"235","author":"Chen","year":"2020","journal-title":"J Cell Physiol"},{"key":"key20260702095041_b153-MI-6-4-00326","doi-asserted-by":"publisher","first-page":"2567","DOI":"10.1089\/ten.TEA.2013.0332","article-title":"Stem cell trials for cardiovascular medicine: Ethical rationale","volume":"20","author":"Niemansburg","year":"2014","journal-title":"Tissue Eng Part A"},{"key":"key20260702095041_b154-MI-6-4-00326","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1177\/15563316251361511","article-title":"Ethical and regulatory considerations related to regenerative medicine","volume":"21","author":"Jayaram","year":"2025","journal-title":"HSS J"},{"issue":"285","key":"key20260702095041_b155-MI-6-4-00326","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-020-02425-6","article-title":"Cardiac stem cell therapy among Clinics of Uncertain Regulatory Status (COURS): Under-regulated, under-observed, incompletely understood","volume":"18","author":"Lindeman","year":"2020","journal-title":"J Transl Med"},{"issue":"3764","key":"key20260702095041_b156-MI-6-4-00326","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-24104-w","article-title":"Preventing post-surgical cardiac adhesions with a catechol-functionalized oxime hydrogel","volume":"12","author":"Fujita","year":"2021","journal-title":"Nat Commun"},{"issue":"1472103","key":"key20260702095041_b157-MI-6-4-00326","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2024.1472103","article-title":"Stem cells and bio scaffolds for the treatment of cardiovascular diseases: New insights","volume":"12","author":"Razavi","year":"2024","journal-title":"Front Cell Dev Biol"},{"key":"key20260702095041_b158-MI-6-4-00326"},{"key":"key20260702095041_b159-MI-6-4-00326"},{"key":"key20260702095041_b160-MI-6-4-00326"},{"key":"key20260702095041_b161-MI-6-4-00326"},{"issue":"138","key":"key20260702095041_b162-MI-6-4-00326","doi-asserted-by":"publisher","DOI":"10.1186\/s13287-020-01648-0","article-title":"Mending a broken heart: Current strategies and limitations of cell-based therapy","volume":"11","author":"Liew","year":"2020","journal-title":"Stem Cell Res Ther"},{"issue":"152","key":"key20260702095041_b163-MI-6-4-00326","doi-asserted-by":"publisher","DOI":"10.3390\/jfb16050152","article-title":"Injectable stem cell-based therapies for myocardial regeneration: A review of the literature","volume":"16","author":"Guo","year":"2025","journal-title":"J Funct Biomater"},{"issue":"943","key":"key20260702095041_b164-MI-6-4-00326","doi-asserted-by":"publisher","DOI":"10.4070\/kcj.2021.0291","article-title":"Biomaterials-based approaches for cardiac regeneration","volume":"51","author":"Vasu","year":"2021","journal-title":"Korean Circ J"},{"issue":"6","key":"key20260702095041_b165-MI-6-4-00326","doi-asserted-by":"publisher","DOI":"10.1038\/s41536-025-00394-2","article-title":"Revitalizing the heart: Strategies and tools for cardiomyocyte regeneration post-myocardial infarction","volume":"10","author":"Bois","year":"2025","journal-title":"NPJ Regen Med"},{"issue":"981982","key":"key20260702095041_b166-MI-6-4-00326","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.981982","article-title":"Cardiac regeneration: Options for repairing the injured heart","volume":"9","author":"Wang","year":"2023","journal-title":"Front Cardiovasc Med"},{"issue":"1674","key":"key20260702095041_b167-MI-6-4-00326","doi-asserted-by":"publisher","DOI":"10.3390\/cells14211674","article-title":"Cells versus cell-derived signals in cardiac regenerative therapy: A comparative analysis of mechanisms and clinical evidence","volume":"14","author":"Soczy\u0144ska","year":"2025","journal-title":"Cells"},{"issue":"681705","key":"key20260702095041_b168-MI-6-4-00326","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2021.681705","article-title":"Bioengineering technologies for cardiac regenerative medicine","volume":"9","author":"Chingale","year":"2021","journal-title":"Front Bioeng Biotechnol"},{"key":"key20260702095041_b169-MI-6-4-00326","doi-asserted-by":"publisher","first-page":"4738","DOI":"10.1093\/eurheartj\/ehad510","article-title":"Cardiac magnetic resonance biomarkers as surrogate endpoints in cardiovascular trials for myocardial diseases","volume":"44","author":"Benz","year":"2023","journal-title":"Eur Heart J"},{"key":"key20260702095041_b170-MI-6-4-00326","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s12265-024-10563-1","article-title":"Past trends and future directions of cardiac regenerative medicine: A systematic analysis of clinical trial registries","volume":"18","author":"Wulfse","year":"2024","journal-title":"J Cardiovasc Transl Res"},{"key":"key20260702095041_b171-MI-6-4-00326","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1097\/HCO.0000000000000956","article-title":"Clinical trials of cell therapy for heart failure: Recent results warrant continued research","volume":"37","author":"Bolli","year":"2022","journal-title":"Curr Opin Cardiol"},{"issue":"641116","key":"key20260702095041_b172-MI-6-4-00326","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.641116","article-title":"Cell-based therapies for heart failure","volume":"12","author":"de Carvalho","year":"2021","journal-title":"Front Pharmacol"},{"issue":"101138","key":"key20260702095041_b173-MI-6-4-00326","doi-asserted-by":"publisher","DOI":"10.1016\/j.mam.2022.101138","article-title":"The evolving regulatory landscape in regenerative medicine","volume":"91","author":"Beetler","year":"2022","journal-title":"Mol Aspects Med"},{"issue":"e002817","key":"key20260702095041_b174-MI-6-4-00326","doi-asserted-by":"publisher","DOI":"10.1136\/openhrt-2024-002817","article-title":"Clinical development and proof-of-principle testing of new regenerative vascular endothelial growth factor-D therapy for refractory angina: Rationale and design of the phase 2 ReGenHeart trial","volume":"11","author":"Leikas","year":"2024","journal-title":"Open Heart"},{"key":"key20260702095041_b175-MI-6-4-00326","doi-asserted-by":"publisher","first-page":"8706","DOI":"10.7150\/thno.114459","article-title":"Molecular and functional MRI enables detection of cardiac fibrosis and evaluation of treatment response after chordin-like 1 gene therapy in myocardial infarction","volume":"15","author":"Amoiradaki","year":"2025","journal-title":"Theranostics"},{"issue":"73","key":"key20260702095041_b176-MI-6-4-00326","doi-asserted-by":"publisher","DOI":"10.1186\/s13287-024-03690-8","article-title":"Pre-clinical evaluation of the efficacy and safety of human induced pluripotent stem cell-derived cardiomyocyte patch","volume":"15","author":"Miyagawa","year":"2024","journal-title":"Stem Cell Res Ther"},{"issue":"e238242","key":"key20260702095041_b177-MI-6-4-00326","doi-asserted-by":"publisher","DOI":"10.14503\/THIJ-23-8242","article-title":"The CardiAMP cell therapy for heart failure trial","volume":"50","author":"Pepine","year":"2023","journal-title":"Tex Heart Inst J"},{"key":"key20260702095041_b178-MI-6-4-00326","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.jacc.2016.11.009","article-title":"Randomized comparison of allogeneic versus autologous mesenchymal stem cells for nonischemic dilated cardiomyopathy: POSEIDON-DCM Trial","volume":"69","author":"Hare","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"93","key":"key20260702095041_b179-MI-6-4-00326","doi-asserted-by":"publisher","DOI":"10.1038\/s43856-025-00787-w","article-title":"AAV9-cBIN1 gene therapy rescues chronic heart failure due to ischemic cardiomyopathy in a canine model","volume":"5","author":"Khan","year":"2025","journal-title":"Commun Med (Lond)"},{"key":"key20260702095041_b180-MI-6-4-00326","doi-asserted-by":"publisher","first-page":"e512","DOI":"10.1016\/j.jtcvs.2023.07.014","article-title":"Stem cell-derived exosome patch with coronary artery bypass graft restores cardiac function in chronically ischemic porcine myocardium","volume":"166","author":"Aggarwal","year":"2023","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"5475","key":"key20260702095041_b181-MI-6-4-00326","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24065475","article-title":"An adjuvant stem cell patch with coronary artery bypass graft surgery improves diastolic recovery in porcine hibernating myocardium","volume":"24","author":"Aggarwal","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"101331","key":"key20260702095041_b182-MI-6-4-00326","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtbio.2024.101331","article-title":"Hydrogel-based cardiac patches for myocardial infarction therapy: Recent advances and challenges","volume":"29","author":"Liu","year":"2024","journal-title":"Mater Today Bio"},{"issue":"345","key":"key20260702095041_b183-MI-6-4-00326","doi-asserted-by":"publisher","DOI":"10.3390\/jcdd12090345","article-title":"AI applied to cardiac magnetic resonance for precision medicine in coronary artery disease: A systematic review","volume":"12","author":"Jim\u00e9nez-Jara","year":"2025","journal-title":"J Cardiovasc Dev Dis"},{"issue":"e71726","key":"key20260702095041_b184-MI-6-4-00326","doi-asserted-by":"publisher","DOI":"10.2196\/71726","article-title":"Coronary computed tomographic angiography to optimize the diagnostic yield of invasive angiography for low-risk patients screened with artificial intelligence: Protocol for the CarDIA-AI randomized controlled trial","volume":"14","author":"Petch","year":"2025","journal-title":"JMIR Res Protoc"},{"key":"key20260702095041_b185-MI-6-4-00326","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1042\/BST20243001","article-title":"Using modified mRNA for cardiomyocyte proliferation and cardiac genetic disease modelling and treatment","volume":"53","author":"Batho","year":"2025","journal-title":"Biochem Soc Trans"},{"key":"key20260702095041_b186-MI-6-4-00326","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s11886-023-01857-y","article-title":"The role of large animal models in cardiac regeneration research using human pluripotent stem cell-derived cardiomyocytes","volume":"25","author":"Cheng","year":"2023","journal-title":"Curr Cardiol Rep"},{"issue":"954","key":"key20260702095041_b187-MI-6-4-00326","doi-asserted-by":"publisher","DOI":"10.3390\/bioengineering11100954","article-title":"Bridging the gap: Advances and challenges in heart regeneration from in vitro to in vivo applications","volume":"11","author":"Watanabe","year":"2024","journal-title":"Bioengineering"},{"key":"key20260702095041_b188-MI-6-4-00326","doi-asserted-by":"publisher","first-page":"2397","DOI":"10.1093\/eurheartj\/ehz787","article-title":"A realistic appraisal of the use of embryonic stem cell-based therapies for cardiac repair","volume":"41","author":"Wysoczynski","year":"2019","journal-title":"Eur Heart J"},{"key":"key20260702095041_b189-MI-6-4-00326","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.jacbts.2016.06.010","article-title":"The promise and challenge of induced pluripotent stem cells for cardiovascular applications","volume":"1","author":"Youssef","year":"2016","journal-title":"JACC Basic Transl Sci"},{"key":"key20260702095041_b190-MI-6-4-00326","first-page":"22","article-title":"From injury to repair: The therapeutic potential of induced pluripotent stem cells in heart failure","volume":"2","author":"Sugiura","year":"2025","journal-title":"Regen Med Rep"},{"issue":"499","key":"key20260702095041_b191-MI-6-4-00326","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-022-02710-9","article-title":"Ethical and regulatory issues of stem cell-derived 3-dimensional organoid and tissue therapy for personalised regenerative medicine","volume":"20","author":"Harris","year":"2022","journal-title":"BMC Med"},{"issue":"783","key":"key20260702095041_b192-MI-6-4-00326","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-024-05499-8","article-title":"Toward the latest advancements in cardiac regeneration using induced pluripotent stem cells (iPSCs) technology: Approaches and challenges","volume":"22","author":"Farboud","year":"2024","journal-title":"J Transl Med"},{"key":"key20260702095041_b193-MI-6-4-00326","doi-asserted-by":"publisher","first-page":"12","DOI":"10.17925\/HI.2025.19.2.3","article-title":"Gut microbiome and cardiovascular health: Mechanisms, therapeutic potential and future directions","volume":"19","author":"Edpuganti","year":"2025","journal-title":"Heart Int"},{"issue":"e211","key":"key20260702095041_b194-MI-6-4-00326","doi-asserted-by":"publisher","DOI":"10.15190\/d.2025.10","article-title":"Artificial intelligence in cardiovascular imaging: Current landscape, clinical impact, and future directions","volume":"13","author":"Edpuganti","year":"2025","journal-title":"Discov (Craiova)"}],"container-title":["Medicine International"],"original-title":[],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T06:50:48Z","timestamp":1782975048000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/mi.2026.326"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,3]]},"references-count":194,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,6,3]]}},"URL":"https:\/\/doi.org\/10.3892\/mi.2026.326","relation":{},"ISSN":["2754-3242","2754-1304"],"issn-type":[{"value":"2754-3242","type":"print"},{"value":"2754-1304","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,3]]}}}